Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.23.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues:        
License and other revenues $ 3,500 $ 1,346
Expenses:        
Royalties 30 1,605 350
Research and development 7,148 5,490 23,712 22,693
General and administrative 4,156 3,890 13,174 11,574
Impairment of licensed technology 1,355
Loss/(gain) on right-of-use lease assets (1,065) 1,561
Impairment of construction-in-progress 1,792
Total expenses 11,334 9,380 37,426 39,325
Loss from operations (11,334) (9,380) (33,926) (37,979)
Interest income 593 72 1,374 103
Interest expense (105) (157) (309) (558)
Change in fair value of warrant liabilities (1,101) 3,050 (7,465) 5,995
Other income (expense) 111 (19) 2,729 (136)
Net loss (11,836) (6,434) (37,597) (32,575)
Deemed dividends related to Series A and Series B Convertible Redeemable Preferred Stock (3,782)
Net loss attributable to Common Shareholders $ (11,836) $ (6,434) $ (37,597) $ (36,357)
Loss per common share - basic $ (0.48) $ (1.00) $ (1.89) $ (6.05)
Loss per common share - diluted $ (0.48) $ (1.00) $ (1.89) $ (6.05)
Weighted average number of common shares outstanding - basic 24,797,564 6,421,245 19,942,613 6,009,902
Weighted average number of common shares outstanding - diluted 24,797,564 6,421,245 19,942,613 6,009,902
Other comprehensive income (loss):        
Change in unrealized gains (losses) related to available-for-sale debt securities $ (33) $ (4) $ 1 $ (11)
Foreign currency translation adjustments 29 (6) 29 (6)
Comprehensive loss $ (11,840) $ (6,444) $ (37,567) $ (36,374)